![Robert Letellier](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profilo
Robert Letellier founded PharmaGap, Inc. in 1999, where he worked as Director from 2010 to 2012 and AB Biotech, Inc. in 2004, where he is working as President, Chief Executive Officer & Director from 2011.
Mr. Letellier received his undergraduate degree from the University of Sherbrooke.
Posizioni attive di Robert Letellier
Società | Posizione | Inizio |
---|---|---|
AB Biotech, Inc.
![]() AB Biotech, Inc. Pharmaceuticals: MajorHealth Technology AB Biotech, Inc. develops and commercializes immunological products. It also develops an immunological approach to sexing semen for all species and humans. The company was founded by Robert Letellier in 2004 and is headquartered in Montréal, Canada. | Fondatore | 21/10/2010 |
Precedenti posizioni note di Robert Letellier
Società | Posizione | Fine |
---|---|---|
PharmaGap, Inc.
![]() PharmaGap, Inc. BiotechnologyHealth Technology PharmaGap, Inc. engages in developing novel peptide therapeutics for the treatment of cancer. The company was founded by Robert Letellier, Jenny Phipps and Michel Phipps on October 6, 1999 and is headquartered in Ottawa, Canada. | Fondatore | - |
Formazione di Robert Letellier
University of Sherbrooke | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 2 |
---|---|
PharmaGap, Inc.
![]() PharmaGap, Inc. BiotechnologyHealth Technology PharmaGap, Inc. engages in developing novel peptide therapeutics for the treatment of cancer. The company was founded by Robert Letellier, Jenny Phipps and Michel Phipps on October 6, 1999 and is headquartered in Ottawa, Canada. | Health Technology |
AB Biotech, Inc.
![]() AB Biotech, Inc. Pharmaceuticals: MajorHealth Technology AB Biotech, Inc. develops and commercializes immunological products. It also develops an immunological approach to sexing semen for all species and humans. The company was founded by Robert Letellier in 2004 and is headquartered in Montréal, Canada. | Health Technology |
- Borsa valori
- Insiders
- Robert Letellier